Appeals court remands patent suit over wasting drug | Business Information & News | Westlaw

Appeals court remands patent suit over wasting drug | Business Information & News | Westlaw

View on Westlaw or start a FREE TRIAL today, Appeals court remands patent suit over wasting drug, Business Information & News
Skip Page Header

Appeals court remands patent suit over wasting drug

Brendan PiersonREUTERS LEGAL (Approx. 4 pages)

Appeals court remands patent suit over wasting drug

Brendan PiersonREUTERS LEGAL (Approx. 4 pages)

12/4/14 REUTERS LEGAL 00:34:23
REUTERS LEGAL
Copyright © 2014 Thomson Reuters
December 4, 2014
Appeals court remands patent suit over wasting drug
Brendan Pierson
(Reuters) - A federal appeals court has ordered a Maryland judge to reconsider a decision invalidating Par Pharmaceutical Inc's patent on an anti-wasting drug.
Judge Kathleen O'Malley of the U.S. Court of Appeals for the Federal Circuit ruled...
---- Index References ----
Company: BRISTOL MYERS SQUIBB CO; PAR PHARMACEUTICAL INC; TWI PHARMACEUTICALS INC
News Subject: (Legal (1LE33); Patents (1PA79); Intellectual Property (1IN75); Judicial Cases & Rulings (1JU36))
Industry: (Pharmaceuticals & Biotechnology (1PH13); Generic Drugs (1GE93); Pharmaceuticals (1PH33); Pharmaceutical Patents (1PH40))
Region: (U.S. Mid-Atlantic Region (1MI18); Maryland (1MA47); Americas (1AM92); North America (1NO39); USA (1US73))
Language: EN
Other Indexing: (Don Mizerk; Todd Hughes; Daniel Brown; Kathleen O'Malley; Evan Wallach; Catherine Blake)
Keywords: ip; health (MCC:OEC); (N2:US); (N2:AMERS); (N2:USA); (MCCL:OVR)
Word Count: 467
End of Document© 2024 Thomson Reuters. No claim to original U.S. Government Works.